アセチルコリンエステラーゼ acetylcholinesterase
WordNet
- a dull persistent (usually moderately intense) pain (同)aching
- have a desire for something or someone who is not present; "She ached for a cigarette"; "I am pining for my lover" (同)yearn, yen, pine, languish
- be the source of pain (同)smart, hurt
PrepTutorEJDIC
- (継続的に鈍く)〈人が〉『痛みを感じる』,〈身体が〉痛む,うずく / 《話》切望する,心から願う / 《しばしば複合語を作って》(継続的な鈍い)『痛み』,うずき
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/07/14 23:32:28」(JST)
wiki ja
| acetylcholinesterase (Yt blood group) | |
|---|---|
|
Diagram of Pacific electric ray acetylcholinesterase. From PDB 1EA5.
|
|
| 識別子 | |
| 略号 | ACHE |
| 遺伝子コード | YT |
| Entrez | 43 |
| HUGO | 108 |
| OMIM | 100740 |
| RefSeq | NM_015831 |
| UniProt | P22303 |
| 他のデータ | |
| EC番号 | 3.1.1.7 |
| 遺伝子座 | Chr. 7 q22 |
| butyrylcholinesterase | |
|---|---|
|
Cartoon diagram of human butyrylcholinesterase. From PDB 1P0I.
|
|
| 識別子 | |
| 略号 | BCHE |
| 遺伝子コード | CHE1 |
| Entrez | 590 |
| HUGO | 983 |
| OMIM | 177400 |
| RefSeq | NM_000055 |
| UniProt | P06276 |
| 他のデータ | |
| EC番号 | 3.1.1.8 |
| 遺伝子座 | Chr. 3 q26.1-26.2 |
コリンエステラーゼ（Cholinesterase,ChE)とは、コリンエステル類を加水分解する酵素である。
種類
2種類がある。
- アセチルコリンエステラーゼ (AChE)
- 神経組織、赤血球などに存在する。コリン作動性神経（副交感神経、運動神経、交感神経の中枢～神経節）の神経伝達物質アセチルコリンを酢酸とコリンに分解する。真性コリンエステラーゼ。
- ブチリルコリンエステラーゼ (BuChE)
- 肝臓、血清などに存在する。AChを含む様々なコリンエステル類を分解する。健康診断などで検査されるChEは、こちらの方である。高値の場合はネフローゼ症候群、脂肪肝など、低値の場合は肝硬変、肝炎、有機リン系薬物中毒（有機リン系の農薬中毒、サリンなどの神経ガス中毒）などが疑われる。偽コリンエステラーゼ。
歴史
1968年にコロンビア大学のWalo Leuzingerらがデンキウナギから精製に成功した。
関連項目
- アセチルコリン
- コリン作動薬
- コリンエステラーゼ阻害剤
| この項目は、医学に関連した書きかけの項目です。この項目を加筆・訂正などしてくださる協力者を求めています（プロジェクト:医学／Portal:医学と医療）。 |
wiki en
For other uses, see Ache.
| acetylcholinesterase | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Acetylcholinesterase catalyzes this hydrolysis of acetylcholine to acetate and choline
|
|||||||||
| Identifiers | |||||||||
| EC number | 3.1.1.7 | ||||||||
| CAS number | 9000-81-1 | ||||||||
| Databases | |||||||||
| IntEnz | IntEnz view | ||||||||
| BRENDA | BRENDA entry | ||||||||
| ExPASy | NiceZyme view | ||||||||
| KEGG | KEGG entry | ||||||||
| MetaCyc | metabolic pathway | ||||||||
| PRIAM | profile | ||||||||
| PDB structures | RCSB PDB PDBe PDBsum | ||||||||
| Gene Ontology | AmiGO / EGO | ||||||||
|
|||||||||
| Acetylcholinesterase | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PDB rendering based on 1b41. |
|||||||||||||
|
|||||||||||||
| Identifiers | |||||||||||||
| Symbols | ACHE ; ACEE; ARACHE; N-ACHE; YT | ||||||||||||
| External IDs | OMIM: 100740 MGI: 87876 HomoloGene: 543 ChEMBL: 220 GeneCards: ACHE Gene | ||||||||||||
| EC number | 3.1.1.7 | ||||||||||||
|
|||||||||||||
| RNA expression pattern | |||||||||||||
| More reference expression data | |||||||||||||
| Orthologs | |||||||||||||
| Species | Human | Mouse | |||||||||||
| Entrez | 43 | 11423 | |||||||||||
| Ensembl | ENSG00000087085 | ENSMUSG00000023328 | |||||||||||
| UniProt | P22303 | P21836 | |||||||||||
| RefSeq (mRNA) | NM_000665 | NM_009599 | |||||||||||
| RefSeq (protein) | NP_000656 | NP_033729 | |||||||||||
| Location (UCSC) | Chr 7: 100.49 – 100.49 Mb |
Chr 5: 137.29 – 137.29 Mb |
|||||||||||
| PubMed search | [1] | [2] | |||||||||||
|
This box:
|
|||||||||||||
Acetylcholinesterase, also known as AChE or acetylhydrolase, is a hydrolase that hydrolyzes the neurotransmitter acetylcholine. AChE is found at mainly neuromuscular junctions and cholinergic brain synapses, where its activity serves to terminate synaptic transmission. It belongs to carboxylesterase family of enzymes. It is the primary target of inhibition by organophosphorus compounds such as nerve agents and pesticides.
Contents
- 1 Enzyme structure and mechanism
- 2 Biological function
- 3 Disease relevance
- 4 Distribution
- 5 AChE gene
- 5.1 AChET
- 5.2 AChEH
- 5.3 AChER
- 6 See also
- 7 References
- 8 Further reading
- 9 External links
Enzyme structure and mechanism
AChe mechanism of action[1]
AChE has a very high catalytic activity - each molecule of AChE degrades about 25000 molecules of acetylcholine (ACh) per second, approaching the limit allowed by diffusion of the substrate.[2][3] The active site of AChE comprises 2 subsites - the anionic site and the esteratic subsite. The structure and mechanism of action of AChE have been elucidated from the crystal structure of the enzyme.[4][5]
The anionic subsite accommodates the positive quaternary amine of acetylcholine as well as other cationic substrates and inhibitors. The cationic substrates are not bound by a negatively-charged amino acid in the anionic site, but by interaction of 14 aromatic residues that line the gorge leading to the active site.[6][7][8] All 14 amino acids in the aromatic gorge are highly conserved across different species.[9] Among the aromatic amino acids, tryptophan 84 is critical and its substitution with alanine results in a 3000-fold decrease in reactivity.[10] The gorge penetrates half way through the enzyme and is approximately 20 angstroms long. The active site is located 4 angstroms from the bottom of the molecule.[11]
The esteratic subsite, where acetylcholine is hydrolyzed to acetate and choline, contains the catalytic triad of three amino acids: serine 200, histidine 440 and glutamate 327. These three amino acids are similar to the triad in other serine proteases except that the glutamate is the third member rather than asparate. Moreover, the triad is of opposite chirality to that of other proteases.[12] The hydrolysis reaction of the carboxyl ester leads to the formation of an acyl-enzyme and free choline. Then, the acyl-enzyme undergoes nucleophilic attack by a water molecule, assisted by the histidine 440 group, liberating acetic acid and regenerating the free enzyme.[13][14][15][16]
Biological function
During neurotransmission, ACh is released from the nerve into the synaptic cleft and binds to ACh receptors on the post-synaptic membrane, relaying the signal from the nerve. AChE, also located on the post-synaptic membrane, terminates the signal transmission by hydrolyzing ACh. The liberated choline is taken up again by the pre-synaptic nerve and ACh is synthetized by combining with acetyl-CoA through the action of choline acetyltransferase.[17][18][19]
Disease relevance
Main article: Acetylcholinesterase inhibitor
For a cholinergic neuron to receive another impulse, ACh must be released from the ACh receptor. This occurs only when the concentration of ACh in the synaptic cleft is very low. Inhibition of AChE leads to accumulation of ACh in the synaptic cleft and results in impeded neurotransmission.[20]
Mechanism of Inhibitors of AChE
Irreversible inhibitors of AChE may lead to muscular paralysis, convulsions, bronchial constriction, and death by asphyxiation. Organophosphates (OP), esters of phosphoric acid, are a class of irreversible AChE inhibitors.[21] Cleavage of OP by AChE leaves a phosphoryl group in the esteratic site, which is slow to be hydrolyzed (on the order of days) and can become covalently bound. Irreversible AChE inhibitors have been used in insecticides (e.g., malathion) and nerve gases for chemical warfare (e.g., Sarin and Soman). Carbamates, esters of N-methyl carbamic acid, are AChE inhibitors that hydrolyze in hours and have been used for medical purposes (e.g., physostigmine for the treatment of glaucoma). Reversible inhibitors occupy the esteratic site for short periods of time (seconds to minutes) and are used to treat of a range of central nervous system diseases. Tetrahydroaminoacridine (THA) and donepezil are FDA-approved to improve cognitive function in Alzheimer's disease. Rivastigmine is also used to treat Alzheimer's and Lewy body dementia, and pyridostigmine bromide is used to treat myasthenia gravis.[22][23][24][25][26][27] Alzheimer disease drugs donepezil, galantamine, and rivastigmine are inhibitors of acetylcholinesterase as well.[15][28]
An endogenous inhibitor of AChE in neurons is Mir-132 microRNA, which may limit inflammation in the brain by silencing the expression of this protein and allowing ACh to act in an anti-inflammatory capacity.[29]
It has also been shown that the main active ingredient in cannabis, tetrahydrocannibinol, is a competitive inhibitor of acetylcholinesterase.[30]
Distribution
AChE is found in many types of conducting tissue: nerve and muscle, central and peripheral tissues, motor and sensory fibers, and cholinergic and noncholinergic fibers. The activity of AChE is higher in motor neurons than in sensory neurons.[31][32][33]
Acetylcholinesterase is also found on the red blood cell membranes, where different forms constitute the Yt blood group antigens.[34] Acetylcholinesterase exists in multiple molecular forms, which possess similar catalytic properties, but differ in their oligomeric assembly and mode of attachment to the cell surface.
AChE gene
In mammals, acetylcholinesterase is encoded by a single AChE gene while some invertebrates have multiple acetylcholinesterase genes. Diversity in the transcribed products from the sole mammalian gene arises from alternative mRNA splicing and post-translational associations of catalytic and structural subunits. There are three known forms: T (tail), R (read through), and H(hydrophobic).[35]
AChET
The major form of acetylcholinesterase found in brain, muscle, and other tissues, known as is the hydrophilic species, which forms disulfide-linked oligomers with collagenous, or lipid-containing structural subunits. In the neuromuscular junctions AChE expresses in asymmetric form which associates with ColQ or subunit. In the central nervous system it is associated with PRiMA which stands for Proline Rich Membrane anchor to form symmetric form. In either case, the ColQ or PRiMA anchor serves to maintain the enzyme in the intercellular junction, ColQ for the neuromuscular junction and PRiMA for synapses.
AChEH
The other, alternatively-spliced form expressed primarily in the erythroid tissues, differs at the C-terminus, and contains a cleavable hydrophobic peptide with a PI-anchor site. It associates with membranes through the phosphoinositide (PI) moieties added post-translationally.[36]
AChER
The third type has, so far, only been found in Torpedo sp. and mice although it is hypothesized in other species. It is thought to be involved in the stress response and, possibly, inflammation.[37]
See also
- Acetylcholinesterase inhibitor
- Cholinesterases
- Proteopedia Acetylcholinesterase
References
- ^ Katzung BG (2001). Basic and clinical pharmacology:Introduction to autonomic pharmacology (8 ed.). The McGraw Hill Companies. pp. 75–91. ISBN 978-0-07-160405-5.
- ^ Quinn DM (1987). "Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states". Chemical Review 87 (5): 955–79. doi:10.1021/cr00081a005.
- ^ Taylor P, Z Radic (1994). "The cholinesterases: from genes to proteins". Annual Review of Pharmacology and Toxicology 34: 281–320. doi:10.1146/annurev.pa.34.040194.001433. PMID 8042853.
- ^ Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (August 1991). "Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein". Science 253 (5022): 872–9. Bibcode:1991Sci...253..872S. doi:10.1126/science.1678899. PMID 1678899.
- ^ Sussman JL, Harel M, Silman I (June 1993). "Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs". Chem. Biol. Interact. 87 (1–3): 187–97. doi:10.1016/0009-2797(93)90042-W. PMID 8343975.
- ^ Radić Z, Gibney G, Kawamoto S, MacPhee-Quigley K, Bongiorno C, Taylor P (October 1992). "Expression of recombinant acetylcholinesterase in a baculovirus system: kinetic properties of glutamate 199 mutants". Biochemistry 31 (40): 9760–7. doi:10.1021/bi00155a032. PMID 1356436.
- ^ Ordentlich A, Barak D, Kronman C, Ariel N, Segall Y, Velan B, Shafferman A (February 1995). "Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase". J. Biol. Chem. 270 (5): 2082–91. doi:10.1074/jbc.270.5.2082. PMID 7836436.
- ^ Ariel N, Ordentlich A, Barak D, Bino T, Velan B, Shafferman A (October 1998). "The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors". Biochem. J. 335 (1): 95–102. PMC 1219756. PMID 9742217.
- ^ Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A (August 1993). "Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket". J. Biol. Chem. 268 (23): 17083–95. PMID 8349597.
- ^ Tougu V (2001). "Acetylcholinesterase: Mechanism of Catalysis and Inhibition". Current Medicinal Chemistry Central Nervous System Agents 1 (2): 155–170. doi:10.2174/1568015013358536.
- ^ Harel, M; Schalk, I; Ehret-Sabatier, L; Bouet, F; Goeldner, M; Hirth, C; Axelsen, PH; Silman, I; Sussman first9 = JL (1993). "Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase". Proceedings of the National Academy of Sciences of the United States of America 90 (19): 9031–5. Bibcode:1993PNAS...90.9031H. doi:10.1073/pnas.90.19.9031. PMC 47495. PMID 8415649.
- ^ Tripathi A (October 2008). "Acetylcholinsterase: A Versatile Enzyme of Nervous System". Annals of Neuroscience 15 (4).
- ^ Pauling L (1946). "Molecular Architecture and Biological Reactions". Chemical & Engineering News 24 (10): 1375. doi:10.1021/cen-v024n010.p1375.
- ^ Fersht A (1985). Enzyme structure and mechanism. San Francisco: W.H. Freeman. p. 14. ISBN 0-7167-1614-3.
- ^ a b Pohanka (2011). "Cholinesterases, a target of pharmacology and toxicology". Biomedical Papers Olomouc 155 (3): 219–229. doi:10.5507/bp.2011.036. PMID 22286807.
- ^ Pohanka M (2012). "Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology". Int J Mol Sci 13 (2): 2219–38. doi:10.3390/ijms13022219. PMC 3292018. PMID 22408449.
- ^ Whittaker V (1990). "The Contribution of Drugs and Toxins to Understanding of Cholinergic Function". Trends in Physiological Sciences 11 (1): 8–13. doi:10.1016/0165-6147(90)90034-6. PMID 2408211.
- ^ Purves D; George J. Augustine, David Fitzpatrick, William C. Hall, Anthony-Samuel LaMantia, James O. McNamara, Leonard E. White (2008). Neuroscience 4th ed. Sinauer Associates. pp. 121–2. ISBN 978-0-87893-697-7. Cite uses deprecated parameters (help)
- ^ Pohanka M (2012). "Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology". International Journal of Molecular Sciences 13 (12): 2219–2238. doi:10.3390/ijms13022219. PMC 3292018. PMID 22408449.
- ^ [citation needed]
- ^ "National Pesticide Information Center-Diazinon Technical Fact Sheet". Retrieved 24 February 2012.
- ^ "Clinical Application: Acetylcholine and Alzheimer's Disease". Retrieved 24 February 2012.
- ^ Stoelting, R.K. (1999). Anticholinesterase Drugs and Cholinergic Agonists", in Pharmacology and Physiology in Anesthetic Practice. Lippincott-Raven. ISBN 978-0-7817-5469-9.
- ^ Taylor, P; Hardman, J.G, Limbird, L.E, Molinoff, P.B., Ruddon, R.W, Gilman, A.G.,eds (1996). "5: Autonomic Pharmacology: Cholinergic Drugs". The Pharmacologial Basis of Therapeutics. THe McGraw-Hill Companies. pp. 161–174. ISBN 978-0-07-146804-6. Cite uses deprecated parameters (help)
- ^ Blumenthal D, Brunton L, Goodman LS, Parker K, Gilman A, Lazo JS, Buxton I (1996). "5: Autonomic Pharmacology: Cholinergic Drugs". Goodman & Gilman's The pharmacological basis of therapeutics. New York: McGraw-Hill. p. 1634. ISBN 978-0-07-146804-6.
- ^ Drachman, D.B.; Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. Kasper, D.L., eds (1998). Harrison's Principles of Internal Medicine (14 ed.). The McCraw-Hill Companies. pp. 2469–2472. ISBN 978-0-07-020291-7. Cite uses deprecated parameters (help)
- ^ Raffe, RB. Autonomic and Somatic Nervous Systems in Netter's Illustrated Pharmacology. Elsevier Health Science. p. 43. ISBN 978-1-929007-60-8.
- ^ Pohanka M (2011). "Alzheimer´s disease and related neurodegenerative disorders: implication and counteracting of melatonin". Journal of Applied Biomedicine 9 (4): 185–196. doi:10.2478/v10136-011-0003-6.
- ^ Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H (2009). "MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase". Immunity 31 (6): 965–73. doi:10.1016/j.immuni.2009.09.019. PMID 20005135.
- ^ Eubanks LM, Rogers CJ, Beuscher AE 4th, Koob GF, Olson AJ, Dickerson TJ, Janda KD (2006). "A molecular link between the active component of marijuana and Alzheimer's disease pathology". Mol Pharm 3 (6): 773–7. doi:10.1021/mp060066m. PMC 2562334. PMID 17140265.
- ^ Massoulie J, Pezzementi L, Bon S, Krejci E, Vallette FM (July 1993). "Molecular and cellular biology of cholinesterases". Progress in Neurobiology 41 (1): 31–91. doi:10.1016/0301-0082(93)90040-Y. PMID 8321908.
- ^ Chacho LW, Cerf JA (1960). "Histochemical localization of cholinesterase in the amphibian spinal cord and alterations following ventral root section". Journal of Anatomy 94 (Pt 1): 74–81. PMC 1244416. PMID 13808985.
- ^ Koelle GB (1954). "The histochemical localization of cholinesterases in the central nervous system of the rat". Journal of Comparative Anatomy 100 (1): 211–35. doi:10.1002/cne.901000108. PMID 13130712.
- ^ Bartels CF, Zelinski T, Lockridge O (May 1993). "Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism". Am. J. Hum. Genet. 52 (5): 928–36. PMC 1682033. PMID 8488842.
- ^ Massoulié J, Perrier N, Noureddine H, Liang D, Bon S (2008). "Old and new questions about cholinesterases". Chem Biol Interact 175 (1–3): 30–44. doi:10.1016/j.cbi.2008.04.039. PMID 18541228.
- ^ "Entrez Gene: ACHE acetylcholinesterase (Yt blood group)".
- ^ Dori A, Ifergane G, Saar-Levy T, Bersudsky M, Mor I, Soreq H, Wirguin I (2007). "Readthrough acetylcholinesterase in inflammation-associated neuropathies". Life Sci 80 (24–25): 2369–74. doi:10.1016/j.lfs.2007.02.011. PMID 17379257.
Further reading
- Silman I, Futerman AH (1988). "Modes of attachment of acetylcholinesterase to the surface membrane". Eur. J. Biochem. 170 (1–2): 11–22. doi:10.1111/j.1432-1033.1987.tb13662.x. PMID 3319614.
- Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991). "Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein". Science 253 (5022): 872–9. Bibcode:1991Sci...253..872S. doi:10.1126/science.1678899. PMID 1678899.
- Soreq H, Seidman S (2001). "Acetylcholinesterase--new roles for an old actor". Nature Reviews Neuroscience 2 (4): 294–302. doi:10.1038/35067589. PMID 11283752.
- Shen T, Tai K, Henchman RH, McCammon JA (2003). "Molecular dynamics of acetylcholinesterase". Acc. Chem. Res. 35 (6): 332–40. doi:10.1021/ar010025i. PMID 12069617.
- Pakaski M, Kasa P (2003). "Role of acetylcholinesterase inhibitors in the metabolism of amyloid precursor protein". Current drug targets. CNS and neurological disorders 2 (3): 163–71. doi:10.2174/1568007033482869. PMID 12769797.
- Meshorer E, Soreq H (2006). "Virtues and woes of AChE alternative splicing in stress-related neuropathologies". Trends Neurosci. 29 (4): 216–24. doi:10.1016/j.tins.2006.02.005. PMID 16516310.
- Ehrlich G, Viegas-Pequignot E, Ginzberg D, et al. (1992). "Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries". Genomics 13 (4): 1192–7. doi:10.1016/0888-7543(92)90037-S. PMID 1380483.
- Spring FA, Gardner B, Anstee DJ (1992). "Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase". Blood 80 (8): 2136–41. PMID 1391965.
- Shafferman A, Kronman C, Flashner Y, et al. (1992). "Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding". J. Biol. Chem. 267 (25): 17640–8. PMID 1517212.
- Getman DK, Eubanks JH, Camp S, et al. (1992). "The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7". Am. J. Hum. Genet. 51 (1): 170–7. PMC 1682883. PMID 1609795.
- Li Y, Camp S, Rachinsky TL, et al. (1992). "Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression". J. Biol. Chem. 266 (34): 23083–90. PMID 1744105.
- Velan B, Grosfeld H, Kronman C, et al. (1992). "The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant". J. Biol. Chem. 266 (35): 23977–84. PMID 1748670.
- Soreq H, Ben-Aziz R, Prody CA, et al. (1991). "Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure". Proceedings of the National Academy of Sciences of the United States of America 87 (24): 9688–92. Bibcode:1990PNAS...87.9688S. doi:10.1073/pnas.87.24.9688. PMC 55238. PMID 2263619.
- Chhajlani V, Derr D, Earles B, et al. (1989). "Purification and partial amino acid sequence analysis of human erythrocyte acetylcholinesterase". FEBS Lett. 247 (2): 279–82. doi:10.1016/0014-5793(89)81352-3. PMID 2714437.
- Lapidot-Lifson Y, Prody CA, Ginzberg D, et al. (1989). "Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis". Proceedings of the National Academy of Sciences of the United States of America 86 (12): 4715–9. Bibcode:1989PNAS...86.4715L. doi:10.1073/pnas.86.12.4715. PMC 287342. PMID 2734315.
- Bazelyansky M, Robey E, Kirsch JF (1986). "Fractional diffusion-limited component of reactions catalyzed by acetylcholinesterase". Biochemistry 25 (1): 125–30. doi:10.1021/bi00349a019. PMID 3954986.
- Gaston SM, Marchase RB, Jakoi ER (1982). "Brain ligatin: a membrane lectin that binds acetylcholinesterase". J. Cell. Biochem. 18 (4): 447–59. doi:10.1002/jcb.1982.240180406. PMID 7085778.
- Ordentlich A, Barak D, Kronman C, et al. (1995). "Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase". J. Biol. Chem. 270 (5): 2082–91. doi:10.1074/jbc.270.5.2082. PMID 7836436.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Ben Aziz-Aloya R, Sternfeld M, Soreq H (1994). "Promoter elements and alternative splicing in the human ACHE gene". Prog. Brain Res. 98: 147–53. doi:10.1016/s0079-6123(08)62392-4. PMID 8248502.
- Massoulie J, Pezzementi L, Bon S, Krejci E, Valette F (1993). "Molecular and Cellular Biology of Cholinesterases". Prog. Brain Res. 41 (1): 31–91. doi:10.1016/0301-0082(93)90040-Y. PMID 8321908.
External links
- ATSDR Case Studies in Environmental Medicine: Cholinesterase Inhibitors, Including Insecticides and Chemical Warfare Nerve Agents U.S. Department of Health and Human Services
- Proteopedia Acetylcholinesterase
- Proteopedia AChE_inhibitors_and_substrates
- Proteopedia AChE_inhibitors_and_substrates_(Part_II)
- Proteopedia AChE bivalent inhibitors AChE_bivalent_inhibitors AChE bivalent inhibitors
- Acetylcholinesterase: A gorge-ous enzyme QUite Interesting PDB Structure article at PDBe
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 神経管欠損の出生前スクリーニングおよび診断 prenatal screening and diagnosis of neural tube defects
- 2. 小児および思春期における無痛性陰嚢腫脹の原因 causes of painless scrotal swelling in children and adolescents
- 3. Pharmacotherapy for anxiety disorders in children and adolescents
- 4. 運動選手における消化器疾患 gastrointestinal disorders in athletes
- 5. 有機リン剤およびカルバメート中毒 organophosphate and carbamate poisoning
English Journal
- Breaking Up Sedentary Behavior: Perceptions From Cancer Survivors.
- Paxton RJ1, Anderson A, Sarkar S, Taylor WC.
- Cancer nursing.Cancer Nurs.2016 Dec 26. [Epub ahead of print]
- BACKGROUND: Limited data exist on the benefits of, barriers to, and potential strategies to break up time spent sitting in cancer survivors. Such data will be meaningful given the consequences of prolonged sitting.OBJECTIVES: The aim of this study was to conduct a mixed-method research study consist
- PMID 26713501
- Bilateral non-traumatic hip fractures in a heavy smoker COPD patient on inhaled steroids.
- Sanel S1, Sezgin G2, Sarıman N3, Ugutmen E1, Solakoglu C1.
- Archives of osteoporosis.Arch Osteoporos.2016 Dec;11(1):8. doi: 10.1007/s11657-016-0259-2. Epub 2016 Jan 18.
- INTRODUCTION: Bilateral proximal femoral fractures without trauma are very rare conditions. They have been reported in connection with osteoporosis, renal osteodystrophy, parathyroid disease, tumors, epileptic seizures, electroconvulsive therapy, and postirradiation.METHOD: We present a case of a 75
- PMID 26781126
- [Medical termination of pregnancy by mifepristone and misoprostol - evaluation of succes rate, complications and satisfaction of patients].
- Frank K, Gerychová R, Janků P, Huser M, Ventruba P.
- Ceská gynekologie / Ceská lékarská spolecnost J. Ev. Purkyne.Ceska Gynekol.2016 Dec;80(6):451-5.
- OBJECTIVE: The purpose of this study was to evaluate the success rate and complications of medical termination of pregnancy up to 49 days of amenorrhea and present the outcome of our phone questionaire of satisfaction of patients.DESIGN: Retrospective analysis.SETTING: Department of Obstetrics and G
- PMID 26741161
Japanese Journal
- ビルド・バック・ベター : アチェ地震津波支援から学ぶ
- 中村 安秀
- 生産と技術 65(1), 87-90, 2013-00-00
- NAID 40019559489
- アルツハイマー型認知症の臨床的改善に対するリバスチグミンの効果 (特集 新しいアルツハイマー型認知症治療薬の使用経験) -- (リバスチグミンの使用経験)
- 中野 倫仁
- 老年精神医学雑誌 23(9), 1106-1108, 2012-09-00
- NAID 40019439162
- 前頭葉機能とBPSDに対するメマンチン著効例に関する報告 (特集 新しいアルツハイマー型認知症治療薬の使用経験) -- (メマンチンの使用経験)
- 橋本 学
- 老年精神医学雑誌 23(9), 1090-1095, 2012-09-00
- NAID 40019439132
Related Links
- アチエ･デ･コンプレックス ビズ オリジナルアクセサリー。 身に付ける人の魅力をアップさせてくれるような、繊細で華奢なデザイン。 いつまでも可愛らしさを忘れない、大人の女性の為のブランドです。
- acheとは。意味や和訳。[動](自)1 [I（[副]）]〈人・体の一部が〉（…で）（たえず，鈍く）痛む，うずく((from, with ...))；〈心・人が〉（…に）痛ましさを感じる((for ...))My head ached.頭痛がしたMy stomach aches [is aching].胃... - goo ...
Related Pictures
★リンクテーブル★
| リンク元 | 「アセチルコリンエステラーゼ」「acetylcholinesterase」 |
| 関連記事 | 「ache」「AC」「ACh」 |
「アセチルコリンエステラーゼ」
- 英
- acetylcholinesterase, AChE
- 同
- 真性コリンエステラーゼ true cholinesterase、特異的コリンエステラーゼ specific cholinesterase
- 関
- コリンエステラーゼ阻害薬、コリンエステラーゼ、アセチルコリン
「acetylcholinesterase」
「ache」
- n.
- 疼痛, (うずくような)痛み
- vi.
- .to have or suffer a continuous, dull pain
- .to feel great sympathy, pity, or the like
- .to feel eager; yearn; long
- n.
- .a continuous, dull pain (in contrast to a sharp, sudden, or sporadic pain).